Related studies showed that the protein PSF represses protooncogene transcription, and VL30 -1 RNA, a mouse noncoding retroelement RNA, binds and releases PSF from a proto-oncogene, activating transcription. Here we show that this mechanism regulates tumorigenesis in human cells, with human RNAs replacing VL30 -1 RNA. A library of human RNA fragments was used to isolate, by affinity chromatography, 5 noncoding RNA fragments that bind to human PSF (hPSF), releasing hPSF from a protooncogene and activating transcription. T he protein PSF (1) contains a DNA-binding domain (DBD) that binds to the regulatory region of a proto-oncogene and represses transcription, and 2 RNA-binding domains (RBDs) that bind VL30-1 RNA, releasing PSF from a repressed protooncogene and activating transcription (2-5). Mouse and human genomes encode homologous PSF proteins with Ϸ95% sequence identity, whereas the VL30-1 gene belongs to a family of mouse noncoding retroelement genes (6) that is not present in the human genome (7). To determine whether the PSF/RNA regulatory mechanism functions in human cells, a library of RNA fragments was constructed from the nuclear RNA repertoire of a human tumor cell, and the library was screened by affinity chromatography for RNAs that bind to human PSF (hPSF). The screen identified 5 hPSF-binding noncoding RNA fragments that release hPSF from a repressed proto-oncogene and activate transcription, similar to VL30-1 RNA. Each human RNA fragment maps to a matching sequence in a different human gene. The following experiments show that human hPSF-binding RNAs are involved in the control of tumorigenesis.
Results
Cloning and Mapping Human RNA Fragments That Bind to hPSFProtein. The finding that VL30-1 RNA, a mouse retroelement RNA that is not encoded in the human genome, binds selectively to hPSF protein and reverses repression of proto-oncogene transcription (2-5), prompted a search for human RNAs that have a similar function as VL30-1 RNA. The procedure involved synthesizing a library of RNA fragments from the nuclear RNA repertoire of a human melanoma line and selecting by affinity chromatography RNA fragments that bind to hPSF. The procedure yielded 5 such RNA fragments, 4 of which were mapped, by sequence identity, within 1 of the following genes: L1PA16, a non-LTR retroelement gene (8); MER11C, a LTR retroelement gene (9); MALAT-1, a noncoding gene (10, 11); or HN, a mitochondrial gene coding for the peptide humanin (12); a fifth fragment, not shown in the figure, maps to a region that has not been characterized ( Fig. 1 and SI Text).The sequence of the HN RNA fragment is 100% identical to a sequence in the mitochondrial 16S ribosomal RNA gene and is 85% identical to positions 21947595-21947823 on nuclear chromosome 17. Further testing showed that the HN RNA fragment is derived from the mitochondrial HN RNA and not from the nuclear RNA (SI Text). The mitochondrial HN RNA might be translocated to the nucleus or derived from a mitochondrial contamination in the nuclear preparation.Release of hPSF from ...